Success of automated algorithmic scheduling in an outpatient setting.
Cronin, Patrick R, and Alexa Boer Kimball. 2014. “Success of Automated Algorithmic Scheduling in an Outpatient Setting.”. The American Journal of Managed Care 20 (7): 570-6.
Search
Search results
399 results found
A multivariate analysis of dermatology missed appointment predictors.
Cronin, Patrick R, Leah DeCoste, and Alexa Boer Kimball. 2013. “A Multivariate Analysis of Dermatology Missed Appointment Predictors.”. JAMA Dermatology 149 (12): 1435-7.
Face time versus test ordering: is there a trade-off?
Stahl, James E, Mark A Drew, Jeffrey Weilburg, Chris Sistrom, and Alexa B Kimball. 2013. “Face Time versus Test Ordering: Is There a Trade-Off?”. The American Journal of Managed Care 19 (10 Spec No): SP362-8.
Prevalence of skin disorders in patients seeking health care.
Sung, Sarah M, and Alexa B Kimball. 2013. “Prevalence of Skin Disorders in Patients Seeking Health Care.”. Mayo Clinic Proceedings 88 (7): 776.
Cutaneous effects of BRAF inhibitor therapy: a case series.
Mattei, P L, M B Alora-Palli, S Kraft, D P Lawrence, K T Flaherty, and A B Kimball. 2013. “Cutaneous Effects of BRAF Inhibitor Therapy: A Case Series.”. Annals of Oncology : Official Journal of the European Society for Medical Oncology 24 (2): 530-37.
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin, Stuart R, Madeleine Duvic, Joan Guitart, Amit G Pandya, Bruce E Strober, Elise A Olsen, Christopher M Hull, et al. 2013. “Topical Chemotherapy in Cutaneous T-Cell Lymphoma: Positive Results of a Randomized, Controlled, Multicenter Trial Testing the Efficacy and Safety of a Novel Mechlorethamine, 0.02%, Gel in Mycosis Fungoides.”. JAMA Dermatology 149 (1): 25-32.
A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we?
Gee, Sarah N, Lisa Zakhary, Nancy Keuthen, Daniela Kroshinsky, and Alexa Boer Kimball. 2013. “A Survey Assessment of the Recognition and Treatment of Psychocutaneous Disorders in the Outpatient Dermatology Setting: How Prepared Are We?”. Journal of the American Academy of Dermatology 68 (1): 47-52.
A new era in skin care: the omics revolution.
Kimball, A B. 2012. “A New Era in Skin Care: The Omics Revolution.”. The British Journal of Dermatology 166 Suppl 2: iii-iv.
Beyond the blot: cutting edge tools for genomics, proteomics and metabolomics analyses and previous successes.
Kimball, A B, R A Grant, F Wang, R Osborne, and J P Tiesman. 2012. “Beyond the Blot: Cutting Edge Tools for Genomics, Proteomics and Metabolomics Analyses and Previous Successes.”. The British Journal of Dermatology 166 Suppl 2: 1-8.
A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
Chang, Anne Lynn S, Maria Alora-Palli, Xinaida T Lima, Tiffany C Chang, Carol Cheng, Connie M Chung, Omar Amir, and Alexa B Kimball. 2012. “A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Efficacy and Safety of Clindamycin 1.2% and Tretinoin 0.025% Combination Gel for the Treatment of Acne Rosacea over 12 Weeks.”. Journal of Drugs in Dermatology : JDD 11 (3): 333-9.